Several evidences suggested that Toll-like receptor 9 (TLR9) plays an important role in atherosclerosis and neuroprotection but the association between the TLR9 and risk for stroke or outcomes after stroke has not been investigated. The aim of the present study was to investigate the association between TLR9 polymorphisms and the risk for ischemic stroke using a case-control study design. We also explored the correlation between the polymorphisms and outcomes after stroke. We enrolled consecutive Korean stroke patients and controls without history of stroke. Four polymorphisms, namely c.-1486T>C, c.-1237C>T, c.1174A>G, and c.2848G>A were examined using polymerase chain reaction followed by direct sequencing. Initially we examined 193 stroke patients and the same number of healthy adults who had no history of stroke as controls. Due to deviation from Hardy-Weinberg equilibrium of initial controls, we performed genetic analysis of two polymorphisms (c.1174A>G and c.2848G>A) for additional 165 controls. The genotype frequency of four polymorphisms did not differ significantly between stroke patients and controls in unadjusted analysis. The variant allele (C) in c.-1486 locus was associated with significantly increased chance of favorable functional outcome at three month after stroke (OR 2.32, 95% CI 1.02~5.26, p = 0.043).
INTRODUCTION
Atherosclerosis in carotid artery or intracranial artery is one of the most important causes of ischemic stroke (1) .
For initiation and progression of atherosclerosis, inflammation and immune systems play an important role (2, 3) .
Both innate and adaptive immune systems are associated with atherosclerosis. Toll-like receptor (TLR), a pattern recognition receptor usually expressed on membranes of macrophage, is central to the innate immune system (4, 5) .
Genetic variations in genes encoding several TLRs affected the susceptibility of certain infectious disease and atherosclerosis (6) .
TLR9 produces various pro-inflammatory cytokines and
plays an important role in the cellular response to bacterial DNA (7) . Recently several evidences suggested that TLR9 plays an important role in atherosclerosis. The activation of 242 TLR9 facilitated the formation of foam cells in vitro (8) and TLR9 expression was found in human carotid atherosclerotic plaque (9) . In contrast, preconditioning with a TLR9 ligand induced neuroprotection against ischemic injury in mice stroke model, which was mediated by brain tumor necrosis factor (10, 11) . However, the association between the TLR9 polymorphisms and risk of stroke or the effect of TLR9 polymorphism on stroke severity or clinical outcome has not been investigated yet. Therefore, the aims of the present study are to investigate whether the TLR9 polymorphisms increase the risk of stroke using a case-control study design, and to examine the effects of the TLR9 polymorphisms on stroke severity and outcomes among Korean stroke patients.
PATIENTS AND METHODS

Study participants
We enrolled consecutive Korean patients with acute ischemic stroke aged more than 20 years old, who had been admitted to Jeju National University Hospital within 7 days of symptom onset between Apr 2009 and May 2010. They were diagnosed as acute ischemic stroke through neurological examination, cranial computed tomography, or magnetic resonance imaging. The controls were healthy Korean adults who visited the hospital for a regular checkup and had no history of stroke. To verify the stroke free status, the interviewer asked each control if he or she had been advised as having had a stroke by a physician or had ever experienced hemiparesis, hemisensory loss, or speech difficulty. We received written informed consent from all participants and this study was approved by the Institutional Review Board of Jeju National University Hospital.
Clinical and laboratory assessment
Fasting venous blood was drawn for laboratory evaluation of hemoglobin, fasting blood glucose from all participants.
We measured height, body weight, systolic and diastolic blood pressure from all participants. Body mass index was calculated by dividing the body weight (in kilograms) by the height (in meters) squared.
Hypertension was defined as a blood pressure of at least 140/90 mmHg or the use of an antihypertensive agent. Diabetes mellitus was defined as a fasting blood glucose level of at least 126 mg/dl or the use of antidiabetic medication. (12) . The severity of stroke was measured using initial National Institutes of Health Stroke Scale (NIHSS) score on the day of admission (13) . Functional outcome of index stroke was measured at three months after onset using modified Rankin score (mRS) (14) . We dichotomized clinical outcome as favorable (mRS 0 to 1) versus poor (mRS 2 to 6).
Genetic analysis
In this study, we examined four polymorphisms, namely c.-1486T>C, c.1237C>T, c.1174A>G, c.2848G>A, which showed higher minor allele frequencies among TLR9 polymorphisms (15) . DNA was extracted from peripheral blood from the participants using the bead beater-phenol extraction method (16) . The exact sequences of the primers used for genotyping of the four polymorphisms were provided as Table 1 
Statistical analysis
For statistical analysis, we compared the baseline characteristics between the stroke patients and controls using chi-square test for categorical variables and Student t-test for continuous variables. To assess deviation from HardyWeinberg equilibrium (HWE) and to compare the genotype and allele frequency between controls and stroke patients, chi-square test was used for the analysis (17) . After unadjusted analysis, multivariable logistic regression analysis was used to estimate independent association between polymorphism and risk for stroke with adjustments for age, sex, laboratory findings and vascular risk factors. Since the atherothrombotic type of ischemic stroke was expected to show significant associations with TLR9 polymorphisms based on previous research, we planned to repeat the analysis for patients with atherothrombotic subtypes of ischemic stroke, namely LAA or SVO to investigate the association between TLR9 polymorphisms and risk of atherothrombotic stroke for subgroup analysis. To explore the associations between TLR9 polymorphisms and stroke severity, we used analysis of covariance with the baseline NIHSS score as a dependent variable to adjust for other covariates. Multivariable logistic regression analysis was used to assess the association between TLR9 polymorphisms and stroke outcomes at three month in addition to unadjusted analysis.
Stata 12 (StataCorp. TX, USA) for Windows was used for all statistical analyses.
RESULTS
Characteristics of participants
During enrollment period, 199 stroke patients were admitted. Among them, six patients refused the participation.
In addition, 193 healthy adults who had no history of stroke were enrolled as controls. The mean age of 386 participants were 66±12 years, and 60% were men. Compared with controls, stroke patients were more likely to be older, to have hypertension, diabetes mellitus, and smoking habit, and to show elevated fasting blood glucose, systolic and diastolic blood pressure ( (Table 4) . Similarly, for subgroup analysis with 100 atherothrombotic stroke patients and controls, the risk for stroke did not differ significantly by genotypes of four TLR9 polymorphisms both in unadjusted and in adjusted analyses.
Associations of TLR9 polymorphisms on stroke severity and outcome
Initial stroke severity measured by NIHSS score did not differ significantly between the patients with wild type and the patients with variant allele for all polymorphisms both in unadjusted analysis and adjusted analysis ( Table 5 ). The proportion of favorable outcome at three month (mRS 0 to Values are mean (95% CI) or adjusted mean (95% CI) *Adjusted for age, sex, onset to arrival time, hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, smoking, fasting blood glucose and TOAST classification. NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin score. Table 6 ).
DISCUSSIONS
The frequencies of genotypes of the four TLR9 polymorphisms in this study were similar to those of other reports from Asian countries including China, Japan, and Korea (18~20). The frequency of variant allele in c.-1237T>C was only 2% and such rarity was also reported in the study from Japan (20) . Since the significant deviation from HWE was found in c.1174A>G and c.2848C>T among control subjects, this led the analysis of additional 165 adults without history of stroke.
In this study, we could not find any association between the four TLR9 polymorphisms and risk of stroke. The results could be explained by 1) since ischemic strokes have often multiple, heterogeneous mechanisms, the effect of polymorphisms on the risk of stroke might be different according to the mechanisms of ischemic stroke. Although we examined the frequencies of genotypes according to subtype of ischemic stroke and found no significant difference among them, the analysis was not adequately powered due to small sample size when divided into four subtypes of ischemic stroke; 2) although the four polymorphisms were known to show differences of functional activities of TLR9 gene, those difference might not be sufficient to cause phenotypic change leading to stroke (21~23).
Among four TLR9 polymorphisms, we found that the patients having the variant allele (C) in c. This study is subject to several limitations. We had rather In conclusion, we could not find significant association between the four TLR9 polymorphisms and risk of stroke in this study. However, the variant allele in c.-1486 locus was associated with significantly improved functional outcomes after stroke, which warrants further exploration.
